Feng XU

IP Consultant (China & Asia )

AstraZeneca

Dr. Feng Xu is a U.S. qualified intellectual property (IP) attorney (NY, CT & USPTO), with a Ph.D. in biochemistry from a U.S. university.  For over 20 years, Dr. Xu has served innovator pharmaceutical companies, as scientist and as IP counsel, in the U.S. as well as China. His clientele includes small start-up companies and large multinational corporations based in China, the U.S. and other countries. Dr. Xu has over 55 legal and scientific publications and presentations on IP strategies and life science research.  He has counselled clients on creating, managing, defending, enforcing and monetizing IP portfolios, concerning wide varieties of life science technologies from small-molecule drugs to biologics, and from biomarkers to chemical processes, and from formulations to platform technologies.